Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Delayed Quote. Delayed  - 07/22 05:35:01 pm
92.07 EUR   +0.03%
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICID : Industry Study, Insights, Statistics and Research ..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
92.9(c) 91.78(c) 91.8(c) 92.04(c) 92.07(c) Last
2 154 049 1 659 943 1 802 747 1 271 785 1 197 327 Volume
-1.05% -1.21% +0.02% +0.26% +0.03% Change
More quotes
Financials (€)
Sales 2016 47 216 M
EBIT 2016 8 161 M
Net income 2016 4 672 M
Debt 2016 16 060 M
Yield 2016 2,89%
Sales 2017 49 263 M
EBIT 2017 9 612 M
Net income 2017 5 518 M
Debt 2017 12 897 M
Yield 2017 3,11%
P/E ratio 2016 16,94
P/E ratio 2017 14,33
EV / Sales2016 1,95x
EV / Sales2017 1,81x
Capitalization 76 137 M
More Financials
Company
Bayer AG is engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
07/27 | 07:30amEarnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICIDES MARKET 2016 : Industry Study, Insights, Statistics and Researc..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBAYER : Holder Broaches Hostile Monsanto Bid -- WSJ
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20 MONSANTO : Views Bayer's Revised Proposal as Financially Inadequate and Insuffic..
07/20DJMONSANTO : Spurns Sweeter Offer -- WSJ
07/20 COVESTRO : shares ‘Chinese innovation’ with the globe
07/20 Monsanto rejects Bayer's sweetened offer, open to talks
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/21DJBIOGEN : CEO to Step Down; Reports Upbeat Earnings, Outlook--Update
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
2015We anticipate a reversal
2014The EUR 100 area as entry point
More Strategies
News from SeekingAlpha
07/20 Bayer investor floats idea of hostile Monsanto bid
07/19 Warren Buffett Finds A Gem
07/19 Bayer investor seeks shareholder vote on Monsanto deal
07/19 REUTERS : Monsanto, Bayer in talks over confidentiality pact
07/18 REUTERS : Monsanto in talks with Bayer over confidentiality agreement
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 110 €
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Helmut Gunter Wilhelm Panke Member-Supervisory Board
Paul Achleitner Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-20.49%83 560
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results